NYLIM
GH icon

New York Life Investment Management’s Guardant Health GH Stock Holding History

New York Life Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
15,329
+4,313
+39% +$433K 0.01% 605
2025
Q4 		$1.13M Buy
+11,016
New +$985K 0.01% 588

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York Life Investment Management's GH Position: Q1 2026 in Review

New York Life Investment Management increased its Guardant Health (GH) stake by 39% in Q1 2026, buying an estimated $433K and bringing the position to 15,329 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #605.

New York Life Investment Management first reported a position in GH in Q4 2025 and has held it in 2 quarters since. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • New York Life Investment Management held 15,329 shares of Guardant Health worth $1.42M as of Q1 2026.
  • New York Life Investment Management bought 4,313 Guardant Health shares in Q1 2026, an estimated $433K.
  • Guardant Health made up 0.01% of New York Life Investment Management's portfolio in Q1 2026, its #605 holding.
  • New York Life Investment Management first reported a position in Guardant Health in Q4 2025 and has held it in 2 quarters since.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.